Comparison of interventional treatment options for coronary calcified nodules: A sub-analysis of the ROTA.shock trial
- PMID: 38796321
- DOI: 10.1016/j.carrev.2024.05.030
Comparison of interventional treatment options for coronary calcified nodules: A sub-analysis of the ROTA.shock trial
Abstract
Background: The optimal treatment for coronary calcified nodules (CNs) is still unclear. The aim of this study was to compare the modification of these lesions by coronary intravascular lithotripsy (IVL) and rotational atherectomy (RA) using optical coherence tomography (OCT).
Methods: ROTA.shock was a 1:1 randomized, prospective, double-arm multi-center non-inferiority trial that compared the use of IVL and RA with percutaneous coronary intervention (PCI) in severely calcified lesions. In 19 of the patients out of this study CNs were detected by OCT in the target lesion and were treated by either IVL or RA.
Results: The mean angle of CNs was significantly larger in final OCT scans than before RA (92 ± 17° vs. 68 ± 7°; p = 0.01) and IVL (89 ± 18° vs. 60 ± 10°; p = 0.03). The CNs were thinner upon final scans than in initial native scans (RA: 17.8 ± 7.8 mm vs. 38.6 ± 13.1 mm; p = 0.02; IVL: 16.5 ± 9.0 mm vs. 37.2 ± 14.3 mm; p = 0.02). Nodule volume did not differ significantly between native and final OCT scans (RA: 0.66 ± 0.12 mm3 vs. 0.61 ± 0.33 mm3; p = 0.68; IVL: 0.64 ± 0.19 mm3 vs. 0.68 ± 0.22 mm3; p = 0.74). Final stent eccentricity was high with 0.62 ± 0.10 after RA and 0.61 ± 0.09 after IVL.
Conclusion: RA or IVL are unable to reduce the volume of the calcified plaque. CN modulation seems to be mainly induced by the stent implantation and not by RA or IVL.
Keywords: Calcified nodules; Intravascular imaging; Intravascular lithotripsy; Percutaneous coronary intervention; Rotational atherectomy.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Tommaso Gori received grant support and speaker's honoraria from Abbott vascular and speaker's honoraria from Boston Scientific and Shockwave Medical. Luise Gaede received speaker's honoraria from Abbott vascular, Boston Scientific and Shockwave Medical. Maren Weferling has received speaker's honoraria from Boston Scientific and Shockwave Medical. Helge Möllmann received speaker's honoraria from Boston Scientific and Shockwave Medical. Holger Nef received grant support and speaker's honoraria from Abbott vascular and Shockwave Medical. All other authors report no relevant conflicts of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous